Product NDC: | 52584-011 |
Proprietary Name: | Chloramphenicol Sodium Succinate |
Non Proprietary Name: | Chloramphenicol Sodium Succinate |
Active Ingredient(s): | 133.27 mg/133.27mg & nbsp; Chloramphenicol Sodium Succinate |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52584-011 |
Labeler Name: | General Injectables and Vaccines, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA062365 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100901 |
Package NDC: | 52584-011-15 |
Package Description: | 1 VIAL in 1 BAG (52584-011-15) > 133.27 mg in 1 VIAL |
NDC Code | 52584-011-15 |
Proprietary Name | Chloramphenicol Sodium Succinate |
Package Description | 1 VIAL in 1 BAG (52584-011-15) > 133.27 mg in 1 VIAL |
Product NDC | 52584-011 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Chloramphenicol Sodium Succinate |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20100901 |
Marketing Category Name | ANDA |
Labeler Name | General Injectables and Vaccines, Inc |
Substance Name | CHLORAMPHENICOL SODIUM SUCCINATE |
Strength Number | 133.27 |
Strength Unit | mg/133.27mg |
Pharmaceutical Classes | Amphenicol-class Antibacterial [EPC],Amphenicols [Chemical/Ingredient] |